Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Single-Payer Healthcare
  • Federal Workers’ Medical Records
  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus

WHAT'S NEW

  • Single-Payer Healthcare
  • Federal Workers' Medical Records
  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Oct 13 2016

Full Issue

Following FDA Warnings, Reports Of Fatalities, Company Discontinues Teething Gel

Other side effects experienced by the infants included seizures, shortness of breath, vomiting and constipation.

Stat: Infant Teething Medicines That Drew FDA Warning Discontinued

A homeopathic product company says it will discontinue the sale of its teething medicines, following federal warnings about their safety and unconfirmed reports linking the medicines to infant deaths. The company, Hyland’s, has manufactured teething tablets and gels — designed to relieve pain and irritability when an infant’s teeth are coming in — for more than 90 years. Hyland’s has “chosen to discontinue the distribution of our Hyland’s teething medicines in the United States,” the company wrote in an open letter published on its website. “This decision was made in light of the recent warning issued by the Food & Drug Administration (FDA) against the use of homeopathic teething tablets and gels. This warning has created confusion among parents and limited access to the medicines.” (Scott, 10/12)

Bloomberg: Giving Teething Babies Homeopathic Remedies Could Kill Them

More than 400 teething babies given homeopathic remedies to help ease gum pain developed serious health problems over the past six years, including seizures, shortness of breath, vomiting, and constipation, according to an investigation by U.S. regulators. At least 10 died. The U.S. Food and Drug Administration is warning parents and care providers about the potential dangers from the teething products, though its investigation isn’t yet complete. The agency said it hasn’t conclusively determined that homeopathic products were directly responsible for the deaths, and it didn’t identify any of the brands. (Cortez, 10/12)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 8
  • Thursday, May 7
  • Wednesday, May 6
  • Tuesday, May 5
  • Monday, May 4
  • Friday, May 1
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF